Church & Dwight Co., Inc. recalled 21,912 bottles of ZICAM Medicated Fruit Drops on October 1, 2025. The recall stems from a labeling mix-up that failed to disclose elderberry as an ingredient. Consumers should stop using the product immediately.
Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.
Consumers and healthcare providers should stop using this product immediately. Contact Church & Dwight Co., Inc. or your healthcare provider for guidance. Notification method: Letter
The recall involves ZICAM Medicated Fruit Drops in elderberry flavor, distributed by Church & Dwight Co., Inc. The product was sold in 25-drop bottles with lot number BE51396303 and an expiration date of May 2027.
The labeling issue misrepresents the product's ingredients. Consumers may unknowingly ingest elderberry, which could pose risks for those allergic to it.
There have been no reported injuries or incidents related to this recall. The classification is considered Class II.
Stop using the product immediately. Contact Church & Dwight Co., Inc. for further guidance on the recall.
For more information, call Church & Dwight Co., Inc. or visit their website. Additional details are available on the FDA enforcement page.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.